Dr Reddy's Laboratories, an integrated global pharmaceutical company, announced that the audit of the company's API manufacturing plant at Miryalaguda, by the US FDA, has been completed on February 21, 2017. The company have been issued a Form 483 with three observations, which the company is addressing.

Total volume of shares traded on the bourses today was lower by 81.22% to 72,666 compared with 22-day average volume of 387,035.

Shares of the company gained Rs 13.4, or 0.46%, to trade at Rs 2,912.45. The total volume of shares traded was 8,033 at the BSE (9.35 a.m., Wednesday).